Inventor · disambiguated record
Guangwen Wei
Also filed as: WEI GUANGWEN
14 granted patents·19 pending applications·84 citations·filing 2003–2021
92Inventor score
Files withWEI GUANGWEN17SUPERLAB FAR EAST LTD12SICHUAN BIOTECHNOLOGY RES CT1SICHUAN HUIYANG LIFE SCIENCE & TECHNOLOGY CORP1SICHUAN UNIV WEST CHINA HOSPITAL1
Top patents by PatentIndex Score
33 records- 0192US12109250B2Methods and compositions for treatment of bone, skin, subcutaneous, mucosal and/or submucosal cancer by percutaneous and/or transmucosal administration of interferonSUPERLAB FAR EAST LTD·Filed 2020·Granted Oct 8, 2024·2 cites·19 claims
- 0292US10874716B2Methods and compositions for treatment of bone, skin, subcutaneous, mucosal and/or submucosal cancer by percutaneous and/or transmucosal administration of interferonSUPERLAB FAR EAST LTD·Filed 2018·Granted Dec 29, 2020·4 cites·20 claims
- 0386US8551469B2Treatment of tumors and viral diseases with recombinant interferon alphaWEI GUANGWEN·Filed 2008·Granted Oct 8, 2013·3 cites·15 claims
- 0485US8287852B2Treatment of viral diseases with recombinant interferon αWEI GUANGWEN·Filed 2009·Granted Oct 16, 2012·7 cites·7 claims
- 0585US7585647B2Nucleic acid encoding recombinant interferonWEI GUANGWEN·Filed 2004·Granted Sep 8, 2009·22 cites·8 claims
- 0682US8114395B2Treatment of viral diseases with recombinant interferon αWEI GUANGWEN·Filed 2008·Granted Feb 14, 2012·6 cites·13 claims
- 0782US7364724B2Recombinant super-compound interferonSICHUAN BIOTECHNOLOGY RES CT·Filed 2003·Granted Apr 29, 2008·27 cites·7 claims
- 0879US8425896B2Treatment of tumors with recombinant interferon alphaWEI GUANGWEN·Filed 2011·Granted Apr 23, 2013·5 cites·14 claims
- 0977US2022339255A1A method for treating tumor by using recombinant interferon with changed spatial configurationSUPERLAB FAR EAST LTD·Filed 2021·Application pending·0 cites
- 1075US10877024B2Methods of determining interferon having direct inhibitory effects on tumors and uses thereofSUPERLAB FAR EAST LTD·Filed 2016·Granted Dec 29, 2020·1 cites·11 claims
- 1175US9944686B2Treatment of tumors with recombinant interferon alphaSUPERLAB FAR EAST LTD·Filed 2013·Granted Apr 17, 2018·2 cites·7 claims
- 1273US8415151B2Crystalline recombinant interferon with altered spatial configuration, three-dimensional structure and uses thereofWEI GUANGWEN·Filed 2010·Granted Apr 9, 2013·2 cites·6 claims
- 1372US10677782B2Methods of determining interferon having direct inhibitory effects on tumors and uses thereofWEI GUANGWEN·Filed 2014·Granted Jun 9, 2020·1 cites·11 claims
- 1469US8846025B2Crystal of recombinant interferon with altered spatial configuration, three-dimensional structure and uses thereofWEI GUANGWEN·Filed 2010·Granted Sep 30, 2014·1 cites·6 claims
- 1566US2021270808A1Methods of determining interferon having direct inhibitory effects on tumors and uses thereofSUPERLAB FAR EAST LTD·Filed 2020·Application pending·0 cites
- 1665US9273109B2Crystal of recombinant interferon with altered spatial configuration, three-dimensional structure and uses thereofSICHUAN HUIYANG LIFE SCIENCE & TECHNOLOGY CORP·Filed 2014·Granted Mar 1, 2016·1 cites·5 claims
- 1765US2009220456A1Uses of interferons with altered spatial structureWEI GUANGWEN·Filed 2009·Application pending·0 cites
- 1863US2018326012A1Method for treating tumor by using recombinant interferon with changed spatial configurationSUPERLAB FAR EAST LTD·Filed 2018·Application pending·0 cites
- 1963US2005079579A1Uses of spatial configuration to modulate protein functionFiled 2004·Application pending·0 cites
- 2062US2015352188A1Methods and compositions for treatment of bone, skin, subcutaneous, mucosal and/or submucosal cancer by percutaneous and/or transmucosal administration of interferonWEI GUANGWEN·Filed 2014·Application pending·0 cites
- 2162US2016022778A1A method for treating tumor by using recombinant interferon with changed spatial configurationWEI GUANGWEN·Filed 2014·Application pending·0 cites
- 2258US2018258151A1Recombinant super-compound interferon and uses thereofSUPERLAB FAR EAST LTD·Filed 2018·Application pending·0 cites
- 2357US2005208019A1Uses of interferons with altered spatial structureWEI GUANGWEN·Filed 2004·Application pending·0 cites
- 2456US2015031859A1Use of new recombinant interferons with altered spatial configuration and three-dimensional structureSUPERLAB FAR EAST LTD·Filed 2014·Application pending·0 cites
- 2556US2013281667A1Uses of spatial configuration to modulate protein functionSUPERLAB FAR EAST LTD·Filed 2013·Application pending·0 cites
- 2655US2023364193A1Combined drug for treating coronarivus disease 2019SICHUAN UNIV WEST CHINA HOSPITAL·Filed 2021·Application pending·0 cites
- 2752US2011027228A1Uses of interferons with altered spatial structureWEI GUANGWEN·Filed 2010·Application pending·0 cites
- 2851US2013184437A9Design and use of new recombinant interferons with altered spatial configuration and three-dimensional structureWEI GUANGWEN·Filed 2012·Application pending·0 cites
- 2950US2011070195A1Uses of spatial configuration to modulate protein functionWEI GUANGWEN·Filed 2010·Application pending·0 cites
- 3049US2015174206A1Uses of interferons with altered spatial structureSUPERLAB FAR EAST LTD·Filed 2015·Application pending·0 cites
- 3149US2006035327A1Recombinant super-compound interferon and uses thereofWEI GUANGWEN·Filed 2005·Application pending·0 cites
- 3243US2008124302A1Uses of Recombinant Super-Compound InterferonsWEI GUANGWEN·Filed 2006·Application pending·0 cites
- 3341US2013273527A1Method for inducing cell senescence by recombinant interferon with altered spatial configurationSUPERLAB FAR EAST LTD·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Guangwen Wei files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →